Melinda Richter
Global Head of JLabs at Johnson & Johnson Innovation
Meet Melinda Richter
Before joining JLABS, Richter was the Founder and CEO of Prescience International, which was dedicated to accelerating research to the patient. Richter created the company after a medical emergency left her questioning the efficiency of the current healthcare system. In her current role, she supports the innovation community by creating capital-efficient commercialization models that help early-stage companies. She is also Board Chair of the California Life Sciences Association and a board member of BIO’s Technology Transfer Committee.
“COVID-19 accelerated trends in the healthcare industry which have and will continue to create more value for everyone. We’ve seen parallel processing in drug development accelerate time to market for life-enhancing, life-saving therapies; collaboration across companies, borders, and types of organizations to meet an urgent health security threat; an increased focus on health equity and diverse clinical trials to bring more potential solutions to people who’ve had marginalized care; and more options to get and cover virtual care outside of traditional institutional offerings. I feel the crisis of COVID-19 demanded creativity, generosity, empathy and pure determination, and each of us played our part.”